About 15 million Americans carrying medical debt on their credit reports were set to see roughly $49 billion in collections erased automatically under a Consumer Financial Protection Bureau final rule. The regulation would have banned consumer reporting agencies from including medical bills on reports sent to lenders and barred lenders from factoring those bills into credit decisions. But a federal court in Texas vacated the rule, leaving millions of consumers in limbo and raising hard questions about whether state-level protections can fill the gap.
Why removing $49 billion in medical collections from credit reports matters right now
Medical debt differs from other consumer obligations in a basic way: it rarely results from a borrowing decision. Hospital bills often stem from emergencies, insurance disputes, or billing errors that patients cannot control. Yet those bills can drag down a credit score for years, raising interest rates on mortgages, auto loans, and credit cards. The CFPB’s own research found that about 15 million people carry medical bills on their credit reports, totaling more than $49 billion in collections.
The agency argued during its rulemaking that medical debt is a poor predictor of whether someone will repay a loan. Removing it, the CFPB said, would give affected consumers immediate score increases and better access to credit without meaningful added risk for lenders. Several states, including Colorado and New York, have already passed laws restricting medical-debt reporting. If six months of post-vacatur data from the major credit bureaus eventually become available, credit scores for consumers in those states should show measurable differences compared with states that lack similar protections. That divergence would test whether federal action was necessary or whether a patchwork of state laws can achieve the same result.
The CFPB rule, the Federal Register, and the Texas court decision
The CFPB first proposed banning medical bills from credit reports, projecting the move would help roughly 15 million people and remove as much as $49 billion in collections. After a public comment period, the bureau finalized the policy, framing it as a targeted fix to what it saw as an unreliable metric of creditworthiness. The final version was then incorporated into Regulation V and detailed in the Federal Register notice published in January 2025, which set out compliance dates and technical amendments to the Fair Credit Reporting Act framework.
Substantively, the rule imposed two core obligations. First, consumer reporting agencies could no longer furnish medical debt information to lenders for most credit decisions. Second, lenders were prohibited from using medical collections that did appear, whether from legacy data or from sources outside the big national bureaus. Together, those provisions were designed to break the feedback loop in which a single emergency room visit could depress a person’s score and raise the cost of borrowing for years.
Before the rule took effect, the credit bureaus had already begun voluntary changes. Equifax, Experian, and TransUnion removed paid medical collections from reports and extended the waiting period before unpaid medical bills could appear. A CFPB analysis of those earlier steps showed measurable credit-score gains for affected consumers, suggesting the final rule would have amplified benefits that were already underway and standardized them nationwide.
The rule never reached full implementation. Per the CFPB’s own regulatory summary, the U.S. District Court for the Eastern District of Texas vacated the regulation in Cornerstone Credit Union League v. CFPB. The court agreed with challengers that the bureau had exceeded its statutory authority, concluding that barring the use of medical debt in virtually all mainstream credit decisions went beyond what the Fair Credit Reporting Act and related provisions allowed. By vacating the rule rather than merely pausing it, the court effectively wiped it from the books unless and until an appeal succeeds or a new rulemaking is undertaken.
What the vacatur means for consumers and states
The immediate consequence is that medical collections can continue to appear on credit reports, subject only to existing voluntary industry practices and any state-level restrictions. Consumers who expected automatic relief under the CFPB’s rule will instead remain dependent on piecemeal protections, including charity-care policies, hospital financial assistance programs, and state laws that limit when or how medical debt can be reported.
For lenders, the decision preserves the status quo: they may still see and use medical debt in underwriting, even if some bureaus have narrowed the flow of that information. That may reduce legal uncertainty in the short term, but it also means continued reliance on a data point the CFPB has argued is weakly correlated with repayment risk.
The ruling also intensifies pressure on states. Legislatures that were waiting to see how the federal rule played out may now consider their own reporting bans or waiting-period rules. Over time, the result could be a patchwork in which a consumer’s access to credit depends heavily on where they live and which state-law protections apply to their medical bills.
Whether that patchwork can replicate the reach of a single national standard remains an open question. The vacated rule would have removed tens of billions of dollars in medical collections from reports across the country in one stroke. In its absence, progress will likely be incremental, driven by state statutes, additional voluntary moves by the credit bureaus, and the outcome of any appeal or future CFPB rulemaking.
